Thus, results obtained from primary CLL cells closely resembled those from the two CLL cell lines, demonstrating an impairment of mutant p53-expressing cells to handle oxidative stress under basal as well as PRIMA-1Met-treated conditions. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.